{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:07:49Z","timestamp":1783904869775,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51075-z","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:44:20Z","timestamp":1778600660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["UBB as an early-stage potential biomarker for breast cancer via modulation of the ubiquitination pathway"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6447-2000","authenticated-orcid":false,"given":"Fatima","family":"Haider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1080-6721","authenticated-orcid":false,"given":"Syeda Abiha Zehra","family":"Jaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4534-1226","authenticated-orcid":false,"given":"Omema","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2994-3884","authenticated-orcid":false,"given":"Amber","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-2648","authenticated-orcid":false,"given":"Nida","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-8573","authenticated-orcid":false,"given":"Alex","family":"von Kriegsheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-0457","authenticated-orcid":false,"given":"Farha","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6750-093X","authenticated-orcid":false,"given":"Zehra","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"51075_CR1","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson, L. & Gathani, T. Understanding breast cancer as a global health concern. Br. J. Radiol. 95, 20211033\u201320211036. https:\/\/doi.org\/10.1259\/bjr.20211033 (2022).","journal-title":"Br. J. Radiol."},{"key":"51075_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J Clin."},{"key":"51075_CR3","doi-asserted-by":"publisher","first-page":"103835","DOI":"10.1016\/j.breast.2024.103835","volume":"79","author":"M Fu","year":"2025","unstructured":"Fu, M. et al. Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050. Breast. 79, 103835\u2013103846 (2025).","journal-title":"Breast."},{"key":"51075_CR4","doi-asserted-by":"publisher","first-page":"1281922","DOI":"10.3389\/fonc.2024.1281922","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang, L. Mammography with deep learning for breast cancer detection. Front. Oncol. 14, 1281922\u20131281838. https:\/\/doi.org\/10.3389\/fonc.2024.1281922 (2024).","journal-title":"Front. Oncol."},{"key":"51075_CR5","doi-asserted-by":"publisher","first-page":"2128388","DOI":"10.1155\/2024\/2128388","volume":"2024","author":"A Aslam","year":"2024","unstructured":"Aslam, A. et al. Assessing awareness, attitude, and practices of breast cancer screening and prevention among general public and physicians in Pakistan: A nation with the highest breast cancer incidence in Asia. Int. J. Breast. Cancer 2024, 2128388\u20132128402 (2024).","journal-title":"Int. J. Breast. Cancer"},{"key":"51075_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-021-00781-1","volume":"23","author":"E Tarighati","year":"2023","unstructured":"Tarighati, E., Keivan, H. & Mahani, H. A review of prognostic and predictive biomarkers in breast cancer. Clin. Exp. Med. 23, 1\u201316. https:\/\/doi.org\/10.1007\/s10238-021-00781-1 (2023).","journal-title":"Clin. Exp. Med."},{"key":"51075_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00853-4","volume":"13","author":"A Sabbaghian","year":"2025","unstructured":"Sabbaghian, A. et al. WFIKKN2 is secreted and elevated in blood plasma of HER2-positive breast cancer patients \u2013 Implications in cancer surveillance and recurrence monitoring. Biomark Res. 13, 142. https:\/\/doi.org\/10.1186\/s40364-025-00853-4 (2025).","journal-title":"Biomark Res."},{"key":"51075_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17020248","volume":"17","author":"M Seres","year":"2025","unstructured":"Seres, M. et al. Dynamic multilevel regulation of EGFR, KRAS, and MYC oncogenes: Driving cancer cell proliferation through (epi) genetic and post-transcriptional\/translational pathways. Cancers. 17, 248. https:\/\/doi.org\/10.3390\/cancers17020248 (2025).","journal-title":"Cancers."},{"key":"51075_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cpr.70050","volume":"58","author":"G Zhou","year":"2025","unstructured":"Zhou, G. et al. Mechanistic insights and therapeutic potentials of ubiquitin-proteasome system in non\u2010small cell lung cancer. Cell Prolif. 58, 1\u201311 (2025).","journal-title":"Cell Prolif."},{"key":"51075_CR10","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1083\/jcb.201902074","volume":"218","author":"L Song","year":"2019","unstructured":"Song, L. & Luo, Z. Q. Post-translational regulation of ubiquitin signaling. J. Cell Biol. 218, 1776\u20131786 (2019).","journal-title":"J. Cell Biol."},{"key":"51075_CR11","doi-asserted-by":"publisher","first-page":"985178","DOI":"10.3389\/fcimb.2022.985178","volume":"12","author":"P Kumar","year":"2022","unstructured":"Kumar, P., Kumar, P., Mandal, D. & Velayutham, R. The emerging role of deubiquitinases (DUBs) in parasites: A foresight review. Front. Cell. Infect. Microbiol. 12, 985178\u2013985195. https:\/\/doi.org\/10.3389\/fcimb.2022.985178 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"51075_CR12","doi-asserted-by":"publisher","first-page":"R215","DOI":"10.1016\/j.cub.2014.02.002","volume":"24","author":"C Heride","year":"2014","unstructured":"Heride, C., Urb\u00e9, S. & Clague, M. J. Ubiquitin code assembly and disassembly. Curr. Biol. 24, R215\u2013R220 (2014).","journal-title":"Curr. Biol."},{"key":"51075_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu, F. et al. Ubiquitination and deubiquitination in cancer: From mechanisms to novel therapeutic approaches. Mol. Cancer 23, 148\u2013198. https:\/\/doi.org\/10.1186\/s12943-024-02046-3 (2024).","journal-title":"Mol. Cancer"},{"key":"51075_CR14","doi-asserted-by":"publisher","first-page":"24628","DOI":"10.1074\/jbc.M116.738567","volume":"291","author":"MI Davis","year":"2016","unstructured":"Davis, M. I. et al. Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models. J. Biol. Chem. 291, 24628\u201324640 (2016).","journal-title":"J. Biol. Chem."},{"key":"51075_CR15","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1523\/JNEUROSCI.2504-21.2022","volume":"42","author":"M Hashimoto","year":"2022","unstructured":"Hashimoto, M. et al. Ubiquitin-specific protease 2 in the ventromedial hypothalamus modifies blood glucose levels by controlling sympathetic nervous activation. J. Neurosci. 42, 4607\u20134618 (2022).","journal-title":"J. Neurosci."},{"key":"51075_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2022","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2212\u2009\u0394\u0394CT method. Methods 25, 402\u2013408 (2022).","journal-title":"Methods"},{"key":"51075_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"51075_CR18","doi-asserted-by":"crossref","unstructured":"Dallakyan, S. & Olson, A. J. Small-molecule library screening by docking with PyRx. In Chemical Biology: Methods and Protocols: Springer Protocols, 243\u2013250 (Humana Press, 2014).","DOI":"10.1007\/978-1-4939-2269-7_19"},{"key":"51075_CR19","unstructured":"Biovia, D. S. Discovery studio visualizer. San Diego, CA, USA. 936, 240\u2013249 (2017)."},{"key":"51075_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/cells13010029","volume":"13","author":"D Spano","year":"2023","unstructured":"Spano, D. & Catara, G. Targeting the Ubiquitin-Proteasome System and recent advances in cancer therapy. Cells 13, 29 (2023).","journal-title":"Cells"},{"key":"51075_CR21","first-page":"1","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng, L., Meng, T., Chen, L., Wei, W. & Wang, P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal. Transduct. Target. Ther. 5, 1\u201328 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"51075_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155435","volume":"21","author":"ES Scarpa","year":"2020","unstructured":"Scarpa, E. S. et al. The ubiquitin gene expression pattern and sensitivity to UBB and UBC knockdown differentiate primary 23132\/87 and metastatic MKN45 gastric cancer cells. Int. J. Mol. Sci. 21, 5435 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"51075_CR23","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1038\/srep02623","volume":"3","author":"C Oh","year":"2013","unstructured":"Oh, C., Park, S., Lee, E. K. & Yoo, Y. J. Downregulation of ubiquitin level via knockdown of polyubiquitin gene Ubb as potential cancer therapeutic intervention. Sci. Rep. 3, 2623\u20132632. https:\/\/doi.org\/10.1038\/srep02623 (2013).","journal-title":"Sci. Rep."},{"key":"51075_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050902","volume":"16","author":"D Pi\u0105tkowska","year":"2024","unstructured":"Pi\u0105tkowska, D. et al. Ubiquitin B, Ubiquitin C, and \u03b2-Catenin as promising diagnostic and prognostic tools in prostate cancer. Cancers. 16, 902. https:\/\/doi.org\/10.3390\/cancers16050902 (2024).","journal-title":"Cancers."},{"key":"51075_CR25","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1038\/s41598-018-21476-w","volume":"8","author":"SJ Chuang","year":"2018","unstructured":"Chuang, S. J., Cheng, S. C., Tang, H. C., Sun, C. Y. & Chou, C. Y. 6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2. Sci. Rep. 8, 3102\u20133111. https:\/\/doi.org\/10.1038\/s41598-018-21476-w (2018).","journal-title":"Sci. Rep."},{"key":"51075_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6262-4","volume":"19","author":"F De Amicis","year":"2019","unstructured":"De Amicis, F. et al. AIB1 sequestration by androgen receptor inhibits estrogen-dependent CCND1 expression in breast cancer cells. BMC. Cancer. 19, 1\u201311. https:\/\/doi.org\/10.1186\/s12885-019-6262-4 (2019).","journal-title":"BMC. Cancer."},{"key":"51075_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/molecules25020358","volume":"25","author":"A Anestis","year":"2020","unstructured":"Anestis, A., Zoi, I., Papavassiliou, A. G. & Karamouzis, M. V. Androgen receptor in breast cancer\u2014Clinical and preclinical research insights. Mol 25, 358\u2013369. https:\/\/doi.org\/10.3390\/molecules25020358 (2020).","journal-title":"Mol"},{"key":"51075_CR28","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1158\/0008-5472.CAN-07-6059","volume":"68","author":"N Miyajima","year":"2008","unstructured":"Miyajima, N. et al. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res. 68, 3486\u20133494 (2008).","journal-title":"Cancer Res."},{"key":"51075_CR29","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3892\/ol.2017.5787","volume":"13","author":"Z Tan","year":"2017","unstructured":"Tan, Z. et al. Lentivirus-mediated RNA interference of tripartite motif 68 inhibits the proliferation of colorectal cancer cell lines SW1116 and HCT116 in vitro. Oncol. Lett. 13, 2649\u20132655 (2017).","journal-title":"Oncol. Lett."},{"key":"51075_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/1570164617666191008093522","volume":"17","author":"N Syed","year":"2020","unstructured":"Syed, N., Ilyas, A., Idrees, F., Zarina, S. & Hashim, Z. Inhibition of USP2 induces apoptosis through down regulation of fatty acid synthase and CCND1 in triple negative breast cancer. Curr. Proteomics. 17, 425\u2013432 (2020).","journal-title":"Curr. Proteomics."},{"key":"51075_CR31","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1101\/gad.1767609","volume":"23","author":"MT Le","year":"2009","unstructured":"Le, M. T. et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23, 862\u2013876 (2009).","journal-title":"Genes Dev."},{"key":"51075_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/bjd.14916","volume":"176","author":"T Wei","year":"2017","unstructured":"Wei, T. et al. Ubiquitin-specific peptidase 2 as a potential link between microRNA\u2010125b and psoriasis. Br. J. Dermatol. 176, 723\u2013731 (2017).","journal-title":"Br. J. Dermatol."},{"key":"51075_CR33","doi-asserted-by":"publisher","first-page":"15057","DOI":"10.18632\/oncotarget.14801","volume":"8","author":"L Peng","year":"2017","unstructured":"Peng, L., Wang, R., Shang, J., Xiong, Y. & Fu, Z. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients. Oncotarget 8, 15057\u201315070. https:\/\/doi.org\/10.18632\/oncotarget.14801 (2017).","journal-title":"Oncotarget"},{"key":"51075_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41419-021-03888-1","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53. CDD 12, 605\u2013615. https:\/\/doi.org\/10.1038\/s41419-021-03888-1 (2021).","journal-title":"CDD"},{"key":"51075_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.addr.2009.01.001","volume":"61","author":"M Nishikawa","year":"2009","unstructured":"Nishikawa, M., Hashida, M. & Takakura, Y. Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv. Drug Deliv. Rev. 61, 319\u2013326 (2009).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"51075_CR36","doi-asserted-by":"publisher","first-page":"10348","DOI":"10.1021\/bi035023f","volume":"42","author":"C Cao","year":"2003","unstructured":"Cao, C., Leng, Y., Liu, X., Yi, Y. & Li, P. Kufe D catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases. Biochem 42, 10348\u201310353 (2003).","journal-title":"Biochem"},{"key":"51075_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0029073","volume":"6","author":"CW Valle","year":"2011","unstructured":"Valle, C. W. et al. Critical role of VCP\/p97 in the pathogenesis and progression of non-small cell lung carcinoma. PLoS One. 6, 1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0029073 (2011).","journal-title":"PLoS One"},{"key":"51075_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0042470","volume":"7","author":"MN Lagu\u00eb","year":"2012","unstructured":"Lagu\u00eb, M. N. et al. Proteomic profiling of a mouse model for ovarian granulosa cell tumor identifies VCP as a highly sensitive serum tumor marker in several human cancers. PLoS One. 7, 1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0042470 (2012).","journal-title":"PLoS One"},{"key":"51075_CR39","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)81067-3","volume":"84","author":"AJ Muslin","year":"1996","unstructured":"Muslin, A. J., Tanner, J. W., Allen, P. M. & Shaw, A. S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84, 889\u2013897 (1996).","journal-title":"Cell"},{"key":"51075_CR40","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/path.5274","volume":"248","author":"CC Yu","year":"2019","unstructured":"Yu, C. C. et al. YWHAZ amplification\/overexpression defines aggressive bladder cancer and contributes to chemo-\/radio\u2010resistance by suppressing caspase\u2010mediated apoptosis. J. Pathol. 248, 476\u2013487 (2019).","journal-title":"J. Pathol."},{"key":"51075_CR41","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/bjc.2017.247","volume":"117","author":"M Ponzetti","year":"2017","unstructured":"Ponzetti, M. et al. Rucci, N. Non-conventional role of haemoglobin beta in breast malignancy. Br. J. Cancer. 117, 994\u20131006 (2017).","journal-title":"Br. J. Cancer"},{"key":"51075_CR42","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.4103\/0973-1482.163761","volume":"14","author":"GJ Wu","year":"2018","unstructured":"Wu, G. J. et al. Elevated expression of matrix metalloproteinase-9 is associated with bladder cancer pathogenesis. J. Cancer Res. Ther. 14, S54\u2013S59 (2018).","journal-title":"J. Cancer Res. Ther."},{"key":"51075_CR43","first-page":"1","volume":"24","author":"Q Abedin","year":"2025","unstructured":"Abedin, Q., von Bibi, K., Hashim, K. A. & Ilyas, A. Identification of potential hub proteins as theragnostic targets in hepatocellular carcinoma through comprehensive quantitative tissue proteomics analysis. Cancer Inf. 24, 1\u201310 (2025).","journal-title":"Cancer Inf."},{"key":"51075_CR44","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41419-024-07168-6","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN. Cell. Death Dis. 15, 788 (2024).","journal-title":"Cell. Death Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51075-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:23:13Z","timestamp":1783902193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51075-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51075"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51075-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study is performed following the Declaration of Helsinki guidelines 1962. Approval was taken from Institutional Bioethics Committee (IBC KU-234\/2021), University of Karachi. Written informed consent was taken from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Original raw mass spectrometry files and peptide level output are of this study are not available. Therefore, partial proteomics data was submitted to the repository.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study limitations"}}],"article-number":"21772"}}